Know Your Source: Protecting Patients from Unsafe Drugs FDA The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea BPC 157: Miracle Healing Peptide or Hidden Danger? Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law